Literature DB >> 29166147

Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.

Phillip L Guichet1, Beringia Y Liu1, Bhushan Desai1, Zul Surani2, Steven Y Cen1, Christopher Lee1.   

Abstract

OBJECTIVE: The objective of our study was to describe the preliminary results of our clinical low-dose CT (LDCT) lung cancer screening program targeting a minority, socioeconomically disadvantaged, high-risk population different from that studied in the National Lung Screening Trial (NLST).
MATERIALS AND METHODS: Community partner clinics in an underserved region of south Los Angeles County referred interested candidates to our program. All patients met National Comprehensive Cancer Network eligibility criteria for lung cancer screening.
RESULTS: From July 21, 2015, through April 3, 2017, 889 individuals were referred to the program. Of the 329 eligible participants, 275 (mean age, 59 years; 52% men) underwent baseline screening LDCT: 84% of patients were black, and 66% had a high school education or less. The median pack-years was 40, and 81% of patients were current smokers. Thirty-one percent of participants reported occupational exposure to one or more known lung carcinogens. Lung CT Screening Reporting and Data System (Lung-RADS) categories were assigned using baseline LDCT examinations: Lung-RADS category 1 or 2 were assigned in 86% of patients, category 3 in 7%, category 4A in 4%, and category 4B or 4X in 3%. Lung cancer has been diagnosed in two of these patients (0.7%) to date: stage IIIB small cell lung carcinoma in one patient and stage IV lung cancer of unknown type in the other patient. Among the 275 patients, 29% had potentially clinically significant incidental findings.
CONCLUSION: Lung cancer screening with LDCT in a minority, socioeconomically disadvantaged, high-risk population is feasible but may yield a different lung cancer profile than screening populations in more privileged communities. More follow-up time is required to determine whether the reduction in lung cancer mortality shown in the NLST applies to this underserved population.

Entities:  

Keywords:  National Lung Screening Trial; cancer screening; low-dose computed tomography; lung cancer; socioeconomically disadvantaged community

Mesh:

Year:  2017        PMID: 29166147     DOI: 10.2214/AJR.17.18853

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  The Impact of Social Determinants of Health on Lung Cancer Screening Utilization.

Authors:  Donghoon Shin; Michael D C Fishman; Michael Ngo; Jeffrey Wang; Christina A LeBedis
Journal:  J Am Coll Radiol       Date:  2022-01       Impact factor: 5.532

2.  Prevalence And Impact of Medical Comorbidities in A Real-World Lung Cancer Screening Population.

Authors:  Harris Majeed; Hong Zhu; Sarah A Williams; Heidi A Hamann; Vijaya Subbu Natchimuthu; Jessica Lee; Noel O Santini; Travis Browning; Tanushree Prasad; Joyce O Adesina; Minh Do; David Balis; Juana Gamarra de Willams; Ellen Kitchell; David H Johnson; Simon J Craddock Lee; David E Gerber
Journal:  Clin Lung Cancer       Date:  2022-04-29       Impact factor: 4.840

3.  Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review.

Authors:  Ernesto Sosa; Gail D'Souza; Aamna Akhtar; Melissa Sur; Kyra Love; Jeanette Duffels; Dan J Raz; Jae Y Kim; Virginia Sun; Loretta Erhunmwunsee
Journal:  CA Cancer J Clin       Date:  2021-05-20       Impact factor: 286.130

4.  The Case for Patient Navigation in Lung Cancer Screening in Vulnerable Populations: A Systematic Review.

Authors:  Christine S Shusted; Julie A Barta; Michael Lake; Rickie Brawer; Brooke Ruane; Teresa E Giamboy; Baskaran Sundaram; Nathaniel R Evans; Ronald E Myers; Gregory C Kane
Journal:  Popul Health Manag       Date:  2018-11-08       Impact factor: 2.459

5.  Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.

Authors:  Ashley E Prosper; Kosuke Inoue; Kathleen Brown; Alex A T Bui; Denise Aberle; William Hsu
Journal:  JAMA Netw Open       Date:  2021-08-02

Review 6.  Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis.

Authors:  Yannan Lin; Mingzhou Fu; Ruiwen Ding; Kosuke Inoue; Christie Y Jeon; William Hsu; Denise R Aberle; Ashley Elizabeth Prosper
Journal:  J Thorac Oncol       Date:  2021-10-06       Impact factor: 15.609

7.  An Analysis of Lung Cancer Screening Beliefs and Practice Patterns for Community Providers Compared to Academic Providers.

Authors:  Marjon Khairy; Duy K Duong; Salma Shariff-Marco; Iona Cheng; Jennifer Jain; Anupama Balakrishnan; Lynn Liu; Aarti Gupta; Ranjani Chandramouli; Ann Hsing; Ann Leung; Baldeep Singh; Viswam S Nair
Journal:  Cancer Control       Date:  2018 Jan-Dec       Impact factor: 3.302

8.  Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up.

Authors:  Michael Lake; Christine S Shusted; Hee-Soon Juon; Russell K McIntire; Charnita Zeigler-Johnson; Nathaniel R Evans; Gregory C Kane; Julie A Barta
Journal:  BMC Cancer       Date:  2020-06-16       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.